MedPage Today) — The FDA approved elinzanetant (Lynkuet), a new type of nonhormonal drug to treat disruptive menopausal hot flashes, Bayer announced on Friday.
 Elinzanetant is now the first and only dual neurokinin (NK) targeted therapy  …
Novel Nonhormonal Drug Approved for Menopause Hot Flashes

 Leave a Comment Leave a Comment 
